entertainment -WSS

entertainment

author：focus 2025-09-27 23:20:05 - browse：9

Adobe

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist meant to prevent certain biotech firms from doing business in the United States.

Legislation proposing that blacklist, known as the BIOSECURE Act, was passed in a 40-1 bipartisan vote on Wednesday by the House Oversight and Accountability Committee. That’s an important development because until now, the House Select Committee on the Chinese Communist Party had handled the bill in the House. That panel is an ad-hoc committee created to build bipartisan consensus on China policies, but it does not have the authority to pass legislation. A Senate committee also passed the BIOSECURE Act nearly unanimously earlier this year.

With the bill out of the Oversight Committee, the goal is for the House to pass it before the July 4 recess. That would set the legislation up to be included in a year-end must-pass legislative package, possibly the National Defense Authorization Act, which Congress has passed every year for decades.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Harvard scientists, with Google, unveil the most detailed brain map ever

hotspot

WSS

UnitedHealth, in a surprise, takes aim at Steward’s physician group

Brain technologies pose threats that are all too real, experts warn

Class action alleges UnitedHealth concealed DOJ probe

First Opinion on colorectal cancer screening: letter and response

Is it ever OK for doctors to lie to their patients?

Class action alleges UnitedHealth concealed DOJ probe

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

focus

ChatGPT in medicine: STAT answers readers' burning questions

Sepsis can kill a child within hours. Here's how hospitals are fighting back

The cancer drug shortage isn’t new — and neither are the solutions

Gut bacteria may contribute to kidney autoimmunity, study finds

Trump demands the U.S. pay no more for drugs than other countries … again

Scientists uncover potential path to treating deadly childhood tumor

FDA approval of Sarepta Duchenne genetic therapy gives me hope

As billionaires fund anti

After affirmative action ruling, medical educators look to 'holistic review'

Most antidepressants don't work on kids, teens, study finds

hotspot

Hundreds died while taking an arthritis drug, but nobody alerted patients

Chemotherapy before breast cancer surgery might fuel metastasis

People with mental disorders often marry others with same

Scientific mystery highlights the blind spots in genomics databases

Empower primary care with adequate payments and technology

Young boy dies in trial for Pfizer Duchenne gene therapy

explore

knowledge

hotspot

hotspot